Here, we found that they were more like a group of grade II and grade IV like gliomas based on the expression of three genes: GPR85, SHOX2 and HMBOX1. The two groups showed distinct clinical, molecular features and prognosis, which were extremely similar to that of grade II and grade IV gliomas, respectively. Here, SHOX2 is linked to glioma.